scientific article published on 01 October 2011 · Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib · YYNN

Durable molecular response despite F317L and E255K mutations: Successful treatment of chronic myeloid leukemia with sequential imatinib, nilotinib and dasatinib

? TBD

scientific article published on 01 October 2011

Ratings
0

Nobody has rated this yet. Be the first!

Lists
0

Instance of

Scholarly article

Author

Simona Soverini

Orietta Spinelli

Subject

dasatinib monohydrate

Myeloid leukemia

Chronic myelogenous leukemia

Wikidata